![]() |
市場調查報告書
商品編碼
1499413
牙科骨移植片和替代品市場:按類型、產品、應用、最終用戶分類 - 全球預測 2024-2030Dental Bone Grafts & Substitutes Market by Type (Allograft, Alloplast, Synthetic Bone Graft), Product (Bio-OSS, Grafton, OsteoGraf), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
牙科骨移植片和替代品市場規模預計2023年為11.4億美元,2024年達到12.2億美元,2030年達到18.7億美元,複合年成長率預計為7.29%。
牙科骨移植片和替代品包括牙科手術中使用的產品和材料,以刺激骨生長並促進骨缺陷或缺失區域的骨再生。這些產品的材料包括人骨、動物骨和合成材料。牙周病、牙齒脫落和口腔疾病的增加增加了全世界老年人和成年人口的骨移植需求。口腔衛生和美學意識的提高也推動了市場的成長。然而,與移植物和替代物相關的高成本可能會讓患者望而卻步。此外,保險實務中牙科手術的覆蓋範圍有限也限制了市場的擴張。組織工程和再生醫學的創新有助於增強移植材料的選擇和程序。此外,3D 列印和人工智慧的採用不斷增加,為未來幾年移植和替代物的發展創造了新的機會。
主要市場統計 | |
---|---|
基準年[2023] | 11.4億美元 |
預測年份 [2024] | 12.2億美元 |
預測年份 [2030] | 18.7億美元 |
複合年成長率(%) | 7.29% |
區域洞察
普及人口老化加劇、健康意識增強、對微創手術的偏好等,美洲牙科骨移植片和替代品有著廣泛的市場。主要集中在生醫材料研究和合成替代品開發以減少對人類和動物源產品的依賴的投資擴大了該地區的市場。在歐洲國家,完善的醫療保健系統和高醫療設備標準支持市場成長。同樣,歐盟 (EU) 嚴格的法規環境可確保產品的安全性和有效性,並影響消費者對新技術的信心。由於醫療旅遊業的增加和醫療基礎設施的改善,中東牙科骨移植片市場正在成長。非洲地區在新興醫療保健產業的成長方面落後,對技術進步的新投資可能是市場成長的潛在因素。在亞太地區,人口成長、政府對醫療保健的支持力度加大以及老年人對微創手術的偏好,為日本、中國和印度等國家的市場擴張鋪平了道路。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在牙科骨移植片和替代品市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對牙科骨移植片和替代品市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該領域競爭性質的寶貴見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在牙科骨移植片和替代品市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The Dental Bone Grafts & Substitutes Market size was estimated at USD 1.14 billion in 2023 and expected to reach USD 1.22 billion in 2024, at a CAGR 7.29% to reach USD 1.87 billion by 2030.
The dental bone grafts & substitutes include products and materials operated in dental surgery to stimulate bone growth and facilitate bone regeneration in areas with bone loss or deficiency. The source for the material of these products can be human bone, animal bone and synthetic material. Rising incidences of periodontal diseases, tooth loss, and oral ailments drive the need for bone graft procedures for the aged and adult population across the globe. Increased awareness about oral hygiene and aesthetic concerns also spur market growth. However, high cost associated with the grafts and substitutes can be prohibitive for patients. Additionally, limited coverage of dental procedures in the insurance sector restricts the spread of the market. Innovations in tissue engineering and regenerative medicine are helping in enhancing graft material options and procedures. In addition, rising incorporation of 3D printing and AI is creating new opportunity for the development of grafts and substitutes in the upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.14 billion |
Estimated Year [2024] | USD 1.22 billion |
Forecast Year [2030] | USD 1.87 billion |
CAGR (%) | 7.29% |
Regional Insights
The Americas have a sufficient market for dental bone grafts and substitutes due to the prevalence of the increased aged population, awareness about health, and preference for minimally invasive surgeries. Investments primarily focused on biomaterial research and the development of synthetic alternatives to reduce dependency on human and animal-derived products expanded the market in the region. In European countries, well-established healthcare systems and high medical device standards support the market's growth. Similarly, the stringent regulatory environment of the European Union ensures that products are safe and effective, influencing consumer confidence in newer technologies. The Middle East is experiencing growth in the dental bone grafts market due to increasing medical tourism and improving healthcare infrastructure. African regions have slow emerging healthcare sectors with new investments in technological advancements, which can be a potential element for the growth of the market. In the APAC region, increased population growth, growing governmental support for healthcare, and an aged population's preferences for minimally invasive surgeries paved the way for the spread of the market in countries such as Japan, China, and India.
Market Insights
The market dynamics represent an ever-changing landscape of the Dental Bone Grafts & Substitutes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dental Bone Grafts & Substitutes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dental Bone Grafts & Substitutes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
ZimVie Inc. Expanded Dental Implant Solutions in Japan with Launch of TSX Implant
ZimVie Inc., a life sciences company in dental and spine solutions, announced the release of the TSX Implant in Japan. The TSX Implant, known for its suitability for immediate use post-extraction and effectiveness in both soft and dense bone. The implant has features such as peri-implant health, consistent bone maintenance at the crestal level, durable osseointegration, and prosthetic stability. [Published On: 2024-02-07]
Innovations in Bone Healing as Renovos Biologics Limited BMP-2 Gained FDA Recognition
Renovos Biologics Limited has received FDA approval for Renovite BMP-2, a cutting-edge synthetic nanoclay gel infused with bone morphogenic protein 2 (BMP-2). Renovite BMP-2 serves as an alternative to traditional bone grafts, facilitating precise and targeted bone regeneration while preventing BMP-2 leakage. The gel is formulated to degrade naturally as new bone tissue forms, enhancing safety and efficacy. [Published On: 2024-01-04]
Strategic Expansion in Bone Regeneration Technologies as Biocomposites Ltd. Acquired Artoss, Inc.
Artoss, Inc., a company in advanced bone graft substitutes employing its unique NanoBone technology acquired by Biocomposites Ltd. company officials highlighted this acquisition as pivotal, enhancing their portfolio with innovative, ready-to-use products and strengthening their position in bone regeneration and infection management solutions in orthopedic care. [Published On: 2023-06-14]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dental Bone Grafts & Substitutes Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dental Bone Grafts & Substitutes Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., BioHorizons, Inc, botiss biomaterials GmbH, Collagen Matrix, Inc., Dentium Co., Ltd, Dentsply Sirona, Geistlich Pharma AG, Hannox International Corp., immer Biomet Holdings, Inc., Institut Straumann AG, Integra LifeSciences Corporation, Johnson & Johnson, LIFENET HEALTH, INC., Maxigen Biotech Inc., Medtronic PLC, NovaBone Products, LLC by Halma plc, Orthofix Medical Inc., Osteogenics Biomedical, Inc., RTI Surgical, Inc., Stryker, and ZimVie Inc..
Market Segmentation & Coverage
TABLE 318